EPISODE · Oct 7, 2025 · 5 MIN
🧬 Blocking TGF-β, Boosting Function, Sotatercept's Early Advantage inPAH
from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC
🚨 Just out in NEJM! In the Phase 3 HYPERION trial, adding sotatercept early in pulmonary arterial hypertension (PAH) slashed clinical worsening risk by 76% vs placebo (HR 0.24, P 💡 Benefits appeared after just 3 doses, with improved 6-min walk, NT-proBNP, and risk scores. Most AEs were mild (epistaxis, telangiectasia). 📊 A game-changer in early PAH therapy. NNT = 5 over 12 months. 🔗 #Cardiology #PulmonaryHypertension #Sotatercept #NEJM #PrecisionMedicine #ClinicalTrials #RightHeart #TGFb #REVEAL #COMPERA
NOW PLAYING
🧬 Blocking TGF-β, Boosting Function, Sotatercept's Early Advantage inPAH
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m